Guerbet S.A. | Balance Sheet

Fiscal year is January-December. All values EUR Millions.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
18
20
54
97
75
107
Total Accounts Receivable
95
99
201
235
198
194
Inventories
98
101
218
266
272
286
Other Current Assets
3
3
36
24
13
19
Total Current Assets
215
224
510
622
558
607
Net Property, Plant & Equipment
197
196
278
269
259
255
Total Investments and Advances
-
-
-
2
8
11
Long-Term Note Receivable
-
1
1
1
-
-
Intangible Assets
36
44
92
106
109
182
Other Assets
1
1
3
2
2
3
Total Assets
460
476
902
1,028
954
1,081
ST Debt & Current Portion LT Debt
39
37
41
67
66
Accounts Payable
35
36
82
123
79
Income Tax Payable
7
11
28
34
39
Other Current Liabilities
46
50
116
101
79
Total Current Liabilities
127
133
267
325
263
Long-Term Debt
62
45
301
331
287
Provision for Risks & Charges
20
23
30
33
35
Deferred Taxes
2
4
2
3
-
Other Liabilities
1
1
-
-
9
Total Liabilities
221
217
620
713
611
Common Equity (Total)
238
259
282
315
342
Total Shareholders' Equity
238
259
282
315
342
Total Equity
238
259
282
315
342
Liabilities & Shareholders' Equity
460
476
902
1,028
954

About Guerbet

View Profile
Address
15 rue des Vanesses
Paris Ile-de-France 93420
France
Employees -
Website http://www.guerbet.com
Updated 07/08/2019
Guerbet SA engages in the research, development, manufacture, and sale of contrast products for medical imaging. The company products portfolio includes diagnostic imaging, and interventional imaging. It operates through the following segments: Magnetic Resonance Imaging, X-ray Imaging, Interventional Radiology & Theranostics, and Imaging Solutions & Services.